P01008 (ANT3_HUMAN) Homo sapiens (Human)
Antithrombin-III UniProtKBInterProSTRINGInteractive Modelling
464 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
27 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Crystal structure of the antithrombin-factor IXa-pentasaccharide complex |
Heteromer P00740; | 2×NAG; 1×NAG; 1×Z9L; 1×CA; 2×MPD; | ||||
Assess | ||||||
2.5A Crystal Structure of the Antithrombin-Thrombin-Heparin Ternary Complex |
Heteromer P00734; | 1×NAG; 1×GU3; 1×NAG; 1×NAG; 8×MPD; 1×NAG; | ||||
Assess | ||||||
ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE |
Heteromer P00734; | 1×YYB; 3×NAG; 1×GU4; | ||||
Assess | ||||||
Crystal Structure of the Antithrombin-S195A Factor Xa-Pentasaccharide Complex |
Heteromer P00742; | 1×NAG; 1×ZDO; 1×CA; 2×NAG; | ||||
Assess | ||||||
2.1 Angstrom structure of a nonproductive complex between antithrombin, synthetic heparin mimetic S… |
Heteromer P00734; | 2×NAG; 1×GU3; 1×NAG; 1×NAG; 12×GOL; 6×SO4; 1×NAG; | ||||
Assess | ||||||
Crystal Structure of a Domain-Swapped Serpin Dimer | homo-2-mer | 1×NAG; 2×NAG; 2×NAG; 2×CIT; | ||||
Assess | ||||||
Crystal structure of antithrombin variant S137A/V317C/T401C with plasma latent antithrombin | homo-2-mer | 2×NAG; 1×NAG; 2×NAG; 1×GOL; | ||||
Assess | ||||||
Crystal structure at 2.6A of the ternary complex between antithrombin, a P14-P8 reactive loop pepti… | homo-2-mer | 7×NDG; 2×NAG; | ||||
Assess | ||||||
Structure of dimeric antithrombin complexed with a P14-P9 reactive loop peptide and an exogenous tr… | homo-2-mer | 7×NAG; 1×GOL; 1×FOR; | ||||
Assess | ||||||
Crystal Structure of Antithrombin-III | homo-2-mer | 2×NAG; 6×NAG; | ||||
Assess | ||||||
Structure of dimeric antithrombin complexed with a P14-P9 reactive loop peptide and an exogenous tr… | homo-2-mer | 6×NDG; 2×NAG; 1×GOL; | ||||
Assess | ||||||
Intermediate structure of antithrombin bound to the natural pentasaccharide | homo-2-mer | 1×NAG; 2×NAG; 1×NAG; 2×ZDO; 2×NAG; | ||||
Assess | ||||||
THE INTACT AND CLEAVED HUMAN ANTITHROMBIN III COMPLEX AS A MODEL FOR SERPIN-PROTEINASE INTERACTIONS | homo-2-mer | |||||
Assess | ||||||
BIOLOGICAL IMPLICATIONS OF A 3 ANGSTROMS STRUCTURE OF DIMERIC ANTITHROMBIN | homo-2-mer | |||||
Assess | ||||||
Crystal Structure of Native Antithrombin in its Monomeric Form | monomer | 2×NAG; 1×NAG; 7×IOD; 1×GOL; | ||||
Assess | ||||||
PLASMA ALPHA ANTITHROMBIN-III | monomer | 1×NAG; 1×NAG; 1×PO4; 2×NAG; 2×MAN; 1×GOL; | ||||
Assess | ||||||
Hyperstable in-frame insertion variant of antithrombin | monomer | 1×NAG; 2×NAG; | ||||
Assess | ||||||
PLASMA BETA ANTITHROMBIN-III | monomer | 2×NAG; 1×NAG; 1×MAN; 1×GOL; | ||||
Assess | ||||||
Crystal Structure of P13 Alanine Variant of Antithrombin | monomer | 1×NAG; 2×NAG; | ||||
Assess | ||||||
PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE | monomer | 2×NAG; 1×Z9L; 1×NAG; | ||||
Assess | ||||||
ANTITHROMBIN/PENTASACCHARIDE COMPLEX | monomer | 1×Z9L; 2×NAG; | ||||
Assess | ||||||
Crystal Structure of P14 Alanine Variant of Antithrombin | monomer | 1×NAG; 1×NAG; 1×NAG; 1×GOL; | ||||
Assess | ||||||
THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE | monomer | 1×NAA; | ||||
Assess | ||||||
Crystal Structure of Antithrombin in the Pentasaccharide-Bound Intermediate State | monomer | 1×NAG; 1×Z9L; 1×NAG; | ||||
Assess | ||||||
N135Q-S380C-ANTITHROMBIN-III | monomer | 2×NAG; 1×NAG; 1×GOL; | ||||
Assess | ||||||
P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III | monomer | 1×NAG; 1×NAG; 1×NAG; 1×GOL; | ||||
Assess | ||||||
IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN | monomer | |||||
Assess |
2 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
1oyh.2.A | monomer | 0.80 | 1×NAG; | 100.00 | ||
Assess | ||||||
1azx.2.A | monomer | 0.78 | 1×Z9L; | 100.00 | ||
Assess |